Article info
PDFAetiology
Cohort study
Perioperative selective serotonin reuptake inhibitor administration is a marker of poor outcomes after surgery
- Correspondence to: Dr Natalie F Holt, Department of Anesthesiology, Yale School of Medicine, 333 Cedar Street, TMP 3, New Haven, CT 06520, USA; natalie.holt{at}post.harvard.edu
Citation
Perioperative selective serotonin reuptake inhibitor administration is a marker of poor outcomes after surgery
Publication history
- First published September 24, 2013.
Online issue publication
November 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions